Understanding C-Terminal Telopeptide of Type I Collagen: Normal vs Optimal Ranges
Also known as: ctx, c-terminal telopeptide, beta-ctx, serum ctx
?What is C-Terminal Telopeptide of Type I Collagen?
CTX is a breakdown product of type I collagen, the primary structural protein in bone. It is measured in blood serum and serves as a biomarker of bone resorption—the process by which osteoclasts break down bone tissue. Elevated CTX levels may suggest increased bone turnover and loss, while low levels can indicate reduced bone remodeling.
!Why It Matters
CTX is a sensitive indicator of bone resorption rate and is commonly used to assess bone health, monitor osteoporosis risk, and evaluate the effectiveness of bone-protective treatments. Abnormally high or low CTX levels can be associated with imbalanced bone metabolism, which may affect fracture risk and skeletal integrity. CTX is particularly useful in tracking changes in bone loss over time.
Reference Ranges
| Range Type | Min | Max | Unit | Note |
|---|---|---|---|---|
| Lab Normal | 0.16 | 0.66 | ng/mL | Standard lab reference range |
| Optimal | 0.3 | 0.6 | ng/mL | Evidence-based optimal range for health |
| Longevity Target | 0.3 | 0.6 | ng/mL | Per longevity medicine research (Attia et al.) |
Lab normal ranges may vary between laboratories. Optimal and longevity targets are based on research literature and should be interpreted with your physician.
Symptoms of Imbalance
- Increased fracture risk or recurrent fractures
- Bone pain or aching joints
- Loss of height or stooped posture
- Reduced bone density on imaging
- Fatigue related to metabolic bone disease
How to Improve Your Levels
- 1Ensure adequate dietary calcium intake (1000–1200 mg daily for adults)
- 2Maintain sufficient vitamin D levels through sunlight exposure or supplementation
- 3Engage in weight-bearing and resistance exercises regularly
- 4Limit excessive caffeine, salt, and alcohol consumption
- 5Consider hormone-modulating therapies if medically appropriate
- 6Work with a healthcare provider to address underlying causes of bone loss
When to Test
CTX testing is recommended for individuals with osteoporosis, family history of bone disease, postmenopausal women, older men, those on bone-affecting medications, and patients monitoring response to bone-protective therapies. Serial measurements (every 3–6 months) are useful for tracking treatment efficacy.
Related Biomarkers
Track your C-Terminal Telopeptide of Type I Collagen with ByoMap
Upload your blood report and get personalized C-Terminal Telopeptide of Type I Collagen ranges based on your age, sex, and ancestry — free.
Try Free — Upload Your Report